Entirety Biomedical develops and manufactures absorbable metal implants with optimized absorption profiles.
Entirety Biomedical has raised $1.2M in total funding. The most recent round was Seed. The last funding was announced in February 2026.
Entirety Biomedical's investors include Michigan Rise, New York Angels, Red Cedar Ventures, Revere Partners, Union Heritage Capital.
Entirety Biomedical is headquartered in East Lansing, United States.
Entirety Biomedical develops and manufactures absorbable metal implants with optimized absorption profiles.
Entirety Biomedical is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Entirety Biomedical — Funding & Investors." VCBacked, February 11, 2026, https://www.vcbacked.co/company/entirety-biomedical. Accessed August 14, 2026.
VCBacked. (2026). Entirety Biomedical — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/entirety-biomedical
{{cite web |title=Entirety Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/entirety-biomedical |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated